SCHEMBL3477239

SCHEMBL3477239

COC(=O)C(C(=O)OC)n1cc(NC(=O)CC2CCCCCC2)c2c(Cl)cccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.46
RAB9A P51151 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
EPHX2 P34913 3/20 0.43
P2RX7 Q99572 3/20 0.43
ALDH1A1 P00352 3/20 0.42
TDP1 Q9NUW8 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
ESR1 P03372 1/20 0.42
POLB P06746 1/20 0.42
TP53 P04637 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NAMPT P43490 1/20 0.41
ROCK2 O75116 1/20 0.39
IL1B P01584 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1594026 0.92 NPC1 (0.44) NPC1RAB9AL3MBTL1EPHX2P2RX7
SCHEMBL177934 0.85 NPC1 (0.46) NPC1RAB9AL3MBTL1EPHX2P2RX7
SCHEMBL177759 0.85 NPC1 (0.46) NPC1RAB9AL3MBTL1EPHX2P2RX7
SCHEMBL1595273 0.82 EPHX2 (0.49) NPC1RAB9AL3MBTL1EPHX2P2RX7
SCHEMBL1594530 0.82 EPHX2 (0.49) NPC1RAB9AL3MBTL1EPHX2P2RX7
SCHEMBL12704324 0.81 EPHX2 (0.47) NPC1RAB9AL3MBTL1EPHX2P2RX7
SCHEMBL13127147 0.80 EPHX2 (0.41) NPC1RAB9AL3MBTL1EPHX2P2RX7
SCHEMBL1595586 0.79 EPHX2 (0.44) NPC1RAB9AL3MBTL1EPHX2P2RX7
SCHEMBL177908 0.79 EPHX2 (0.44) NPC1RAB9AL3MBTL1EPHX2P2RX7
SCHEMBL177987 0.78 EPHX2 (0.46) NPC1RAB9AL3MBTL1EPHX2P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243772-A1 Novel P2X7R antagonists and their use Affectis Pharmaceuticals AG (DE) 2010-10-27 EP disclosed